GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹318 Cr | ₹241 Cr | ₹187 Cr | ₹137 Cr | ₹98 Cr |
What is the latest Total Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹318 Cr |
| Mar2024 | ₹241 Cr |
| Mar2023 | ₹187 Cr |
| Mar2022 | ₹137 Cr |
| Mar2021 | ₹98 Cr |
How is Total Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹318 Cr | 31.87 | |
| Mar2024 | ₹241 Cr | 29.13 | |
| Mar2023 | ₹187 Cr | 36.30 | |
| Mar2022 | ₹137 Cr | 39.37 | |
| Mar2021 | ₹98 Cr | - | |
Compare Total Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,440.6 Cr | -12.5% | -22.9% | -0.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -12.5% |
-22.9% |
-0.8% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses